News Digest / Ticker: OCUL

Ticker: OCUL

08:00am, Monday, May 05, 2025

Ocular Therapeutix Reports Q1 2025 Results: Revenues Dip 27.7% Amid Rising Expenses and Losses

Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported its financial results for Q1 2025, revealing a mix of achievements and ongoing challenges. Positive Aspects of Income Statement: Net Revenue: The company generated $10.7 million in total net revenue, including $10.6 million from product revenue, w...